Units, standards, and other things that quietly hold the world together — setting out what I have, and where I think it stops being reliable.
Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim.
Something adjacent that I have been thinking about and that does not belong in any of the technical categories. No question in particular; I am interested in how other people see it.
Picking up the opening post: that is the part I would want checked first.
Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
Worth separating two things that post #3 runs together.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
Picking up post #8: that is the part I would want checked first.
Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
Coming back to post #10, because the follow-up matters more than the original answer.
Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's core but not central.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
This follows post #12 rather than contradicting it.
Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.
The correction was fair and I had been repeating something I had not checked carefully enough.
On post #19 — agreed on the reasoning, with one qualification.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
post #23 answers the question as asked. The question underneath it is different.
Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
Coming back to post #27, because the follow-up matters more than the original answer.
Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
Picking up post #27: that is the part I would want checked first.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.